Skip to Main Content

Author Details

Anna DeFazio
Westmead Hospital
1972
201
50
PMIDPaper TitleJournal TitlePublished Year
38051468Follow-up assessment of sleep-related symptoms in patients after treatment for cancer: responses to continuous positive airway pressure treatment for co-morbid obstructive sleep apnoea.Sleep Breath2024
38051468Follow-up assessment of sleep-related symptoms in patients after treatment for cancer: responses to continuous positive airway pressure treatment for co-morbid obstructive sleep apnoea.Sleep Breath2024
36287571A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.J Pathol2023
36368129Profiling the immune landscape in mucinous ovarian carcinoma.Gynecol Oncol2023
36366810Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan.J Gynecol Oncol2023
36287571A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.J Pathol2023
36209449Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort.Cancer Causes Control2023
36401943Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.Gynecol Oncol2023
37339172The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.Clin Cancer Res2023
36512174Screening for obstructive sleep apnoea in post-treatment cancer patients.Cancer Rep (Hoboken)2023
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
37457131Immune checkpoint inhibitors in ovarian cancer: where do we go from here?Cancer Drug Resist2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37071628Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study.PLoS One2023
36805919Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma.Transl Oncol2023
36744914Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study.J Natl Cancer Inst2023
37369443Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.Can J Surg2023
36720497Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary.J Immunother Cancer2023
37457131Immune checkpoint inhibitors in ovarian cancer: where do we go from here?Cancer Drug Resist2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37339172The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.Clin Cancer Res2023
37369443Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.Can J Surg2023
37071628Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study.PLoS One2023
36720497Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary.J Immunother Cancer2023
36401943Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.Gynecol Oncol2023
36744914Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study.J Natl Cancer Inst2023
36512174Screening for obstructive sleep apnoea in post-treatment cancer patients.Cancer Rep (Hoboken)2023
36805919Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma.Transl Oncol2023
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
36209449Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort.Cancer Causes Control2023
36368129Profiling the immune landscape in mucinous ovarian carcinoma.Gynecol Oncol2023
36366810Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan.J Gynecol Oncol2023
34782936MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.Virchows Arch2022
35454861CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.Cancers (Basel)2022
36222710Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.Clin Cancer Res2022
35816189Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.Clin Cancer Res2022
36210504Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.J Natl Cancer Inst2022
35804177Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study.Support Care Cancer2022
35470503Cancer sleep symptom-related phenotypic clustering differs across three cancer specific patient cohorts.J Sleep Res2022
35400525Germline BRCA variants, lifestyle and ovarian cancer survival.Gynecol Oncol2022
36456881The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.Nat Genet2022
34789471High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.Cancer Epidemiol Biomarkers Prev2022
34782936MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.Virchows Arch2022
34897700Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.J Pathol2022
34955238Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns).Gynecol Oncol2022
34697060DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.Cancer Epidemiol Biomarkers Prev2022
35804177Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study.Support Care Cancer2022
35470503Cancer sleep symptom-related phenotypic clustering differs across three cancer specific patient cohorts.J Sleep Res2022
35400525Germline BRCA variants, lifestyle and ovarian cancer survival.Gynecol Oncol2022
35454861CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.Cancers (Basel)2022
  • 1 - 50 of 402

Recommended Authors

Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 5
Divya Gupta
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 2
Zhuo Chen
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 5
Aparna A Kamat
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 3
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 21
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 15
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 15
Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 2
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 25
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 2
Denise C Connolly
Fox Chase Cancer Center
Career Start Year 1993
Number of shared co-authors 10
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 11
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 21
Barry R Davies
Oncology R&D
Career Start Year 1992
Number of shared co-authors 9
Rosemarie Schmandt
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 5
Ramona F Swaby
Merck & Co., Inc.
Career Start Year 1991
Number of shared co-authors 8
Anil K Sood
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 47
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 21
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 20
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 4
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 26
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 10
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 9
Adrian L Harris
University of Oxford
Career Start Year 1981
Number of shared co-authors 13
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 20
Kathleen I Pritchard
UCL Great Ormond Street Institute of Child Health, University College London
Career Start Year 1976
Number of shared co-authors 19
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 70
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 2
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 6

Collaborators

David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 61
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 53
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 44
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 44
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 43
Sian Fereday
Peter MacCallum Cancer Centre
Co-authored papers 43
Catherine J Kennedy
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers 42
Paul Harnett
Westmead Clinical School, University of Sydney
Co-authored papers 40
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 39
Andrew Berchuck
Duke School of Medicine
Co-authored papers 37
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 35
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 35
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 34
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 32
David G Huntsman
University of British Columbia
Co-authored papers 31
Sharon E Johnatty
QIMR Berghofer Medical Research Institute
Co-authored papers 31
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 31
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 30
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 30
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 30
Anna H Wu
University of Southern California
Co-authored papers 29
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 29
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 28
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 28
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 27
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers 26
Martin K??bel
University of Calgary
Co-authored papers 26
Yoke-Eng Chiew
Westmead Hospital
Co-authored papers 25
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 24
Stacey J Winham
Mayo Clinic
Co-authored papers 24
Release 1.2